FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 251 through 265 of 265

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
VALN Nasdaq Valneva SE 2830
VCYT Nasdaq Veracyte, Inc. 2830
VSTM Nasdaq Verastem, Inc. 2830
VTVT Nasdaq vTv Therapeutics Inc. 2830
VYNE Nasdaq VYNE Therapeutics Inc. 2830
WHGLY Over the counter WH Group Limited 2830
XBIO Nasdaq Xenetic Biosciences, Inc. 2830
XBIT Nasdaq XBiotech Inc. 2830
XCUR Nasdaq Exicure, Inc. 2830
XENE Nasdaq Xenon Pharmaceuticals Inc. 2830
XNCR Nasdaq Xencor, Inc. 2830
XOMA Nasdaq XOMA Royalty Corporation 2830
XRTX Nasdaq XORTX Therapeutics Inc. 2830
ZTS New York Zoetis Inc. 2830
ZYBT Nasdaq Zhengye Biotechnology Holding Limited 2830
Results 250 through 265 of 265